Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB21765ApprovedVaccines
Influenza A virus A/Croatia/10136RV/2023 X-425A (H3N2) antigen (formaldehyde inactivated) is a component of an inactivated influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that helps to protect against infection from influenza viruses.
- First approval
- United States, 2024
- Brand names
- Fluzone 2023-2024
- Fluzone 2024-2025
- Fluzone Trivalent 2025 Southern Hemisphere
Resolves to
Compound
Clinical / RWD
What you can answer from here — as of April 23, 2025
Which companies are running trials of Influenza A virus A/Croatia/10136RV/2023 X-425A (H3N2) antigen (formaldehyde inactivated), in which indications and phases, and which of those programs are still active?